Your browser doesn't support javascript.
loading
Prior breast cancer and tamoxifen exposure does not influence outcomes in women with uterine papillary serous carcinoma.
Pierce, Stuart R; Stine, Jessica E; Gehrig, Paola A; Havrilesky, Laura J; Secord, Angeles A; Nakayama, John; Snavely, Anna C; Moore, Dominic T; Kim, Kenneth H.
Affiliation
  • Pierce SR; University of North Carolina, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Chapel Hill, NC, United States. Electronic address: Stuart.Pierce@unchealth.unc.edu.
  • Stine JE; University of North Carolina, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Chapel Hill, NC, United States.
  • Gehrig PA; University of North Carolina, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Chapel Hill, NC, United States; Lineberger Clinical Cancer Center, University of North Carolina, Chapel Hill, NC, United States.
  • Havrilesky LJ; Duke University, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Durham, NC, United States.
  • Secord AA; Duke University, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Durham, NC, United States.
  • Nakayama J; Duke University, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Durham, NC, United States.
  • Snavely AC; Lineberger Clinical Cancer Center, University of North Carolina, Chapel Hill, NC, United States.
  • Moore DT; Lineberger Clinical Cancer Center, University of North Carolina, Chapel Hill, NC, United States.
  • Kim KH; University of North Carolina, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Chapel Hill, NC, United States; Lineberger Clinical Cancer Center, University of North Carolina, Chapel Hill, NC, United States.
Gynecol Oncol ; 144(3): 531-535, 2017 03.
Article de En | MEDLINE | ID: mdl-28062116

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tamoxifène / Tumeurs de l'utérus / Tumeurs du sein / Cystadénocarcinome séreux / Cystadénocarcinome papillaire / Antagonistes des oestrogènes Type d'étude: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Middle aged Pays/Région comme sujet: America do norte Langue: En Journal: Gynecol Oncol Année: 2017 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tamoxifène / Tumeurs de l'utérus / Tumeurs du sein / Cystadénocarcinome séreux / Cystadénocarcinome papillaire / Antagonistes des oestrogènes Type d'étude: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Middle aged Pays/Région comme sujet: America do norte Langue: En Journal: Gynecol Oncol Année: 2017 Type de document: Article Pays de publication: États-Unis d'Amérique